Articles with public access mandates - bruno vincenziLearn more
Not available anywhere: 2
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
R Geva, L Vecchione, KT Kalogeras, BV Jensen, HJ Lenz, T Yoshino, ...
Gut 64 (6), 921-928, 2015
Mandates: Research Foundation (Flanders), Government of Spain, Government of Italy
Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
S Noh, C Nessim, EZ Keung, CL Roland, D Strauss, G Sivarajah, M Fiore, ...
Annals of surgery 278 (2), 267-273, 2023
Mandates: US National Institutes of Health
Available somewhere: 36
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
P Sperone, A Ferrero, F Daffara, A Priola, B Zaggia, M Volante, D Santini, ...
Endocrine-related cancer 17 (2), 445-453, 2010
Mandates: Canadian Institutes of Health Research
Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer
DJ Pinato, A Zambelli, J Aguilar-Company, M Bower, CCT Sng, R Salazar, ...
Cancer discovery 10 (10), 1465-1474, 2020
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective …
DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ...
The Lancet Oncology 22 (12), 1669-1680, 2021
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Nirogacestat, a γ-secretase inhibitor for desmoid tumors
M Gounder, R Ratan, T Alcindor, P Schöffski, WT Van Der Graaf, BA Wilky, ...
New England Journal of Medicine 388 (10), 898-912, 2023
Mandates: US National Institutes of Health
High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
EP Spugnini, S Buglioni, F Carocci, M Francesco, B Vincenzi, M Fanciulli, ...
Journal of Translational Medicine 12, 1-10, 2014
Mandates: Government of Italy
Activity of pazopanib and trabectedin in advanced alveolar soft part sarcoma
S Stacchiotti, O Mir, A Le Cesne, B Vincenzi, A Fedenko, RG Maki, ...
The oncologist 23 (1), 62-70, 2018
Mandates: US National Institutes of Health
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
DJ Pinato, M Patel, L Scotti, E Colomba, S Dolly, A Loizidou, J Chester, ...
JAMA oncology 8 (1), 114-122, 2022
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
F Pantano, M Croset, K Driouch, N Bednarz-Knoll, M Iuliani, G Ribelli, ...
Oncogene 40 (7), 1284-1299, 2021
Mandates: German Research Foundation, National Institute of Health and Medical …
HSulf-1 modulates FGF2-and hypoxia-mediated migration and invasion of breast cancer cells
A Khurana, P Liu, P Mellone, L Lorenzon, B Vincenzi, K Datta, B Yang, ...
Cancer research 71 (6), 2152-2161, 2011
Mandates: US National Institutes of Health
Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre …
DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ...
The Lancet Oncology 23 (7), 865-875, 2022
Mandates: US National Institutes of Health, Cancer Research UK, National Institute for …
Electroporation enhances bleomycin efficacy in cats with periocular carcinoma and advanced squamous cell carcinoma of the head
EP Spugnini, M Pizzuto, M Filipponi, L Romani, B Vincenzi, F Menicagli, ...
Journal of Veterinary Internal Medicine 29 (5), 1368-1375, 2015
Mandates: Government of Italy
Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin
RK Thakur, VK Yadav, A Kumar, A Singh, K Pal, L Hoeppner, D Saha, ...
Nucleic acids research 42 (18), 11589-11600, 2014
Mandates: US National Institutes of Health, Council of Scientific and Industrial …
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
GM Dettorre, S Dolly, A Loizidou, J Chester, A Jackson, U Mukherjee, ...
Journal for ImmunoTherapy of Cancer 9 (3), 2021
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
DJ Pinato, L Scotti, A Gennari, E Colomba-Blameble, S Dolly, A Loizidou, ...
European Journal of Cancer 150, 190-202, 2021
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Immunotherapy in hepatocellular carcinoma
CAM Fulgenzi, T Talbot, SM Murray, M Silletta, B Vincenzi, A Cortellini, ...
Current Treatment Options in Oncology 22, 1-19, 2021
Mandates: National Institute for Health Research, UK, Wellcome Trust
Systemic treatments in MDM2 positive intimal sarcoma: a multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
AM Frezza, T Assi, S Lo Vullo, E Ben‐Ami, A Dufresne, K Yonemori, ...
Cancer 126 (1), 98-104, 2020
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Efficacy and safety of frontline systemic therapy for advanced HCC: a network meta-analysis of landmark phase III trials
CAM Fulgenzi, B Scheiner, J Korolewicz, CV Stikas, A Gennari, ...
JHEP Reports 5 (5), 100702, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial
MM Gounder, AA Razak, N Somaiah, S Chawla, J Martin-Broto, ...
Journal of Clinical Oncology 40 (22), 2479-2490, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program